Form 8-K - Current report:
SEC Accession No. 0001005286-23-000122
Filing Date
2023-11-20
Accepted
2023-11-20 16:09:05
Documents
13
Period of Report
2023-11-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20231120.htm   iXBRL 8-K 29703
2 EX-99.1 dojdeclinationletter.htm EX-99.1 7147
  Complete submission text file 0001005286-23-000122.txt   166048

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20231120.xsd EX-101.SCH 1983
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20231120_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20231120_pre.xml EX-101.PRE 12591
7 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20231120_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 231422836
SIC: 2834 Pharmaceutical Preparations